Univadis - a service form MSD

A trusted medical reference

Create an account Log in

app catalog Search

Log in

Close

My Account

Loading...

Medical News Medical Quiz eLearning Conference Reports Delete Oncology Radiology Collection Delete PubMed Delete Link Library Delete MSD Manual Delete Patient Resource Centre Install new apps

See all my apps Hide my apps

Install new apps Manage my apps

Rearrange your apps by dragging them or delete them with the cross.

Save Cancel

Welcome. Please log in or create an account.

Log in

Remember me (Uncheck if on a shared computer)

Forgot your Password ?

Please review the fields marked in red and resubmit the form

Create an account

Register to access independent medical news and resources from Univadis^®

Latest updates

Medical News

New research presented at EuroEcho 2019 in Austria last week.

Bariatric surgery improves subclinical myocardial function

Univadis Medical News
10 December 2019

New research presented at EuroEcho 2019 in Austria last week.

Survey finds agreement on resuscitation and drug treatment but disparities in the use of bowel rest.

Consensus on management of chemo-induced diarrhoea across Europe

Univadis Medical News
10 December 2019

Survey finds agreement on resuscitation and drug treatment but disparities in the use of bowel rest.

The findings add to a growing list of potential health implications related to e-cigarette use.

E-cigarette use linked to clinical depression

Univadis Medical News
10 December 2019

The findings add to a growing list of potential health implications related to e-cigarette use.

More Medical News >

Conference Reports

ASH 2019 – Ixazomib with rituximab and dexamethasone effective in Waldenstrom’s macroglobulinemia

Univadis
10 December 2019

Combination was feasible with a manageable safety profile.

ASH 2019 – Multiple myeloma: gamma-secretase inhibitor increases antitumor activity of BCMA CAR-T cells

Univadis
10 December 2019

No patient relapsed at a median follow-up of 5 months.

ASH 2019 – Peripheral T-cell lymphoma: nivolumab shows modest activity

Univadis
10 December 2019

Studies targeting this pathway with anti-programmed cell death protein 1/nivolumab are limited.

More Conference Reports >

Featured Channels

application icon

Oncology Oncology essentials all in one place

application icon

Zika All you need to know about Zika virus

Keep up with oncology literature in minutes, every day

Get your daily dose of the latest evidence published in your cancer area of practice
Get my daily Newsletter

Univadis^®

Univadis^®, provided by MSD, brings you unbiased, relevant medical news as well as helpful resources for your daily practice at no cost.

Our Partners

Univadis^® brings together premium content publishers that deliver comprehensive and up-to-date medical information.

Contact Us

E-mail Us

Complete contact form >

MSD does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-MSD sources. Please read our Terms of Use for more information

Privacy Policy | Transparency Policy

Copyright © 2019 Aptus Health International, Inc. All rights reserved.